Place an order request to the broker. The personal manager will contact you to confirm the order.

Order Summary

Asset: Select instrument
Quantity: -
Price per Unit: ? This price is indicative and shown for informational purposes only. The final execution price may change. -
Total Amount: -

Order Expiration

Order remains active until you cancel it or it gets filled

Order expires at the end of the selected day

Order Placed Successfully

Your order has been submitted! Our team will contact you shortly to confirm.

Order Type: -
Asset: -
Quantity: -
Total Amount: -
Manually record a past trade to keep your portfolio up to date. This helps track your P&L accurately.
Total Amount: $0.00

Trade Added Successfully

Trade recorded! Your portfolio data will be recalculated.

Type: -
Asset: -
Quantity: -
Price: -
Total: -

Chat Options

Web Search
Search the internet for recent information
Portfolio Context
Include your portfolio in the conversation
Market Data
Access real-time market information
Watchlist Context
Include your watchlist companies

UiPath, Inc. (PATH)

2026-04-02T13:51:18.706889+00:00

Key Updates

UiPath shares declined 2.18% to $10.74 on April 2, 2026, erasing the March 31 recovery and returning to the post-earnings low established on March 27. The latest decline occurred following Grant Thornton's announcement that its subsidiary Auxis achieved Diamond Partner status, which paradoxically highlighted UiPath's ecosystem strength but failed to reverse negative sentiment. The stock now trades at a critical support level, with YTD losses expanding to 34.44% and 6-month declines reaching 15.73%, significantly underperforming broader market indices. The persistent weakness despite positive partner news and strong product announcements suggests investor concerns about decelerating revenue growth guidance continue to overshadow operational achievements.

Current Trend

UiPath remains entrenched in a severe downtrend with YTD losses of 34.44%, establishing $10.74 as a critical technical support level tested three times since March 27. The stock has formed a pattern of failed recoveries, with each bounce of 2-3% quickly reversed, indicating sustained selling pressure and lack of institutional conviction. The 6-month decline of 15.73% reflects ongoing concerns about the company's ability to sustain growth momentum in an increasingly competitive AI automation landscape. Short-term volatility has compressed around the $10.70-$11.20 range, with the stock failing to establish any meaningful upward momentum despite a steady stream of positive operational news. The technical setup suggests PATH is consolidating at a critical inflection point, with a break below $10.70 likely triggering accelerated selling toward the $9-10 range, while a sustained move above $11.50 would be required to signal a trend reversal.

Investment Thesis

The investment thesis centers on UiPath's strategic pivot toward agentic AI automation, positioning the company to capture enterprise demand for autonomous workflow solutions that extend beyond traditional RPA. The company has achieved significant milestones including first-time GAAP profitability with $57 million in operating income for fiscal 2026, strong cash generation of $371 million from operations, and completion of a $1 billion buyback program with an additional $500 million authorized. UiPath's product portfolio has expanded significantly with industry-specific solutions for financial services, retail, and manufacturing, supported by the WorkFusion acquisition that strengthens its position in regulated industries. The company's achievement of AIUC-1 certification establishes it as the first enterprise automation platform to meet rigorous AI agent security standards, providing a competitive moat in risk-sensitive enterprise deployments. However, the thesis faces headwinds from decelerating ARR growth (11% YoY to $1.853 billion) and conservative fiscal 2027 revenue guidance projecting only 9% growth versus 13% in fiscal 2026, raising questions about market saturation and competitive pressures from Microsoft, ServiceNow, and other automation platforms.

Thesis Status

The investment thesis remains partially intact but under pressure. UiPath has successfully executed its strategic transformation toward agentic AI, achieving profitability and maintaining strong cash generation, which validates the operational components of the bull case. The company's ecosystem strength is evident from Auxis achieving Diamond Partner status, demonstrating partner commitment and implementation expertise. However, the market's negative reaction to slower revenue growth guidance fundamentally challenges the thesis, as investors question whether the company can sustain premium valuations with single-digit growth rates. The disconnect between operational achievements (new product launches, certifications, partnerships) and stock performance suggests investors are pricing in either market share erosion or broader concerns about AI disruption to traditional automation platforms. The thesis requires validation through accelerated customer adoption metrics and improved growth trajectory in coming quarters to restore investor confidence.

Key Drivers

The primary near-term driver remains investor sentiment around UiPath's growth deceleration, with fiscal 2027 revenue guidance of approximately 9% growth creating persistent selling pressure despite operational execution. Product innovation continues as a positive driver, with new agentic solutions for financial services and retail/manufacturing optimization tools demonstrating the company's ability to address vertical-specific use cases. Competitive positioning remains mixed, with Nucleus Research categorizing UiPath as an "Expert" rather than "Leader" in its RPA Technology Value Matrix, suggesting market perception of relative positioning versus competitors. Strategic partnerships provide incremental support, including collaboration with Microsoft on security automation, though this also highlights dependency on ecosystem players who could become competitors. The AIUC-1 certification achievement establishes differentiation in enterprise security requirements, potentially creating switching costs for regulated industries.

Technical Analysis

UiPath has established a critical support zone at $10.70-$10.74, tested three times since March 27 without breaking down, suggesting potential accumulation at this level despite weak momentum. The stock trades in a tight consolidation range between $10.70 and $11.20, with declining volume indicating reduced conviction from both buyers and sellers. The pattern of failed recoveries—2.26% gain on March 31 followed by 2.18% decline on April 2—demonstrates inability to sustain upward momentum and suggests overhead resistance remains formidable around $11.20-$11.50. The YTD decline of 34.44% has established a clear downtrend channel, with the stock trading well below all major moving averages. A decisive break below $10.70 would likely trigger stop-loss selling and accelerate declines toward the $9.50-$10.00 range, representing another 10-12% downside. Conversely, a sustained move above $11.50 with increasing volume would be required to signal trend reversal and attract momentum buyers. The current technical setup suggests PATH is at an inflection point, with the next significant move likely to be directional rather than range-bound.

Bull Case

Bear Case

  • Significant revenue growth deceleration signaling market saturation: UiPath guided fiscal 2027 revenue growth of approximately 9%, down from 13% in fiscal 2026, indicating potential market maturation, increased competition, or customer hesitation around automation investments, which challenges premium valuation multiples for a growth-stage technology company.
  • Competitive positioning downgraded in independent analyst assessment: Nucleus Research categorized UiPath as an "Expert" rather than "Leader" in its 2026 RPA Technology Value Matrix, placing it behind competitors including Appian, Automation Anywhere, Microsoft Power Automate, and others, suggesting relative loss of market positioning despite product innovation efforts.
  • Persistent negative market reaction despite positive operational news: The stock declined more than 4% in after-hours trading following earnings that beat expectations and has failed to sustain any recovery attempts, indicating fundamental investor concerns about the business model or competitive threats that operational metrics have not addressed.
  • Severe YTD underperformance indicating loss of investor confidence: With YTD losses of 34.44% significantly underperforming broader market indices, PATH demonstrates systematic selling pressure and loss of institutional support, suggesting investors are repositioning capital toward higher-growth opportunities or perceiving structural challenges in the automation market.
  • Dependency on partnerships with potential competitors: UiPath's collaboration with Microsoft on security automation highlights strategic dependency on ecosystem players who operate competing automation platforms (Power Automate), creating risk that partners could leverage integration knowledge to develop competing solutions or prioritize their own platforms.

CapPilot is AI-powered and can make mistakes. Please double-check responses.

CapPilot leverages generative AI to distill market insights and analysis, as well as answer your questions in chat. While we work hard to ensure accuracy, AI-generated content may occasionally contain inaccuracies or outdated information.

We value your feedback — reporting errors helps us continuously improve.